Compound class:
Natural product
|
|
References |
1. Behrle AC, Douglas J, Leeder JS, van Haandel L. (2022)
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a Urinary Biomarker of Cytochrome P450 2D6 (CYP2D6) Activity. Drug Metab Dispos, 50 (10): 1342-51. [PMID:35878926] |
2. Gao L, Chen F, Li X, Xu S, Huang W, Ye Y. (2016)
Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway. Bioorg Med Chem Lett, 26 (19): 4735-4738. [PMID:27567371] |
3. Magliocco G, Desmeules J, Matthey A, Quirós-Guerrero LM, Bararpour N, Joye T, Marcourt L, Queiroz EF, Wolfender JL, Gloor Y et al.. (2021)
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. Br J Pharmacol, 178 (23): 4708-4725. [PMID:34363609] |
4. Wollmann BM, Størset E, Kringen MK, Molden E, Smith RL. (2023)
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. Eur J Clin Pharmacol, 79 (4): 523-531. [PMID:36806969] |